TrialInvestigational new drugs2012

A single-arm pilot phase II study of gefitinib and irinotecan in children with newly diagnosed high-risk neuroblastoma.

Wayne L Furman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.